Relationship between Hodgkin's and non-Hodgkin's lymphomas

Medical Oncology

Volumn 20, Issue 3, 2003, Pages 211-220

  Amini, Rose Marie ^a   Enblad, Gunilla ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Clonality; Hodgkin's lymphoma; Interrelationship; Non Hodgkin's lymphoma

Indexed keywords

CD15 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; GRANZYME B; IMMUNOGLOBULIN LIGHT CHAIN; PERFORIN; PROTEIN BCL 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

B CELL LYMPHOMA; B LYMPHOCYTE; BIOPSY; CANCER CLASSIFICATION; CANCER RISK; CELL INTERACTION; CLONE; COMORBIDITY; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EOSINOPHIL; HISTIOCYTE; HISTOLOGY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; INFLAMMATORY CELL; LARGE CELL LYMPHOMA; LYMPHATIC LEUKEMIA; MAST CELL; METASTASIS; MORPHOLOGY; NONHODGKIN LYMPHOMA; OBSERVATION; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REED STERNBERG CELL; REVIEW; T CELL LYMPHOMA; T LYMPHOCYTE; TUMOR CELL; WORLD HEALTH ORGANIZATION;

HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN;

EID: 0141636466     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:20:3:211     Document Type: Review

References (71)

1. Harris, N.L., et al. (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84:1361-1392.
2. Jaffe, E.S. and Mueller-Hermelink, K. (1999). Relationship between Hodgkin's disease and non-Hodgkin's lymphomas, in Hodgkin's Disease (P.M. Mauch, et al., eds), pp181-193, Lippincott Williams & Wilkins, Philadelphia.
3. Küppers, R., et al. (1994). Hodgkin's disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc. Natl. Acad. Sci. 91:10,962-10,966.
4. Kanzler, H., Küppers, R., Hansmann, M.L. and Rajewsky, K. (1996). Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone dervied from (crippled) germinal center B cells. J. Exp. Med. 184:1495-1504.
5. Bennet, M.H., MacLennan, K.A., Vaughan Hudson, G. and Vaughan Hudson, B. (1991). Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20 year experience. Ann. Oncol. 2:83-92.
6. Henry-Amar, M. (1992). Second cancer after treatment for Hodgkin's disease: a report from the international database on Hodgkin's disease. Ann. Oncol. 3:117-128.
7. Henry-Amar, M. and Joly, F. (1996). Late complications after Hodgkin's disease. Ann. Oncol. 7:115-126.
8. Rüffer, U., et al. (2001). Non-Hodgkin's lymphoma after primary Hodgkin's disease the German Hodgkin's Lymphoma Study Group: incidence, treatment and prognosis. J. Clin. Oncol. 19(7):2026-2032.
9. Dores, G.M., et al. (2002). Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J. Clin. Oncol. 20:3484-3494.
10. Travis, L.B., Gonzales, C.L., Hankey, B.F. and Jaffe, E.S. (1992). Hodgkin's disease following non-Hodgkin's lymphoma. Cancer 69:2337-2342.
11. Jaffe, E.S., Zarate-Osorno, A., Kingma, D.W., Raffeld, M. and Medeiros, L.J. (1994). The interrelationship between Hodgkin's disease and non-Hodgkin's lymphoma. Ann. Oncol. 5:7-11.
12. Amini, R.-M., Enblad, G., Sundström, C. and Glimelius, B. (1997). Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients. Int. J. Cancer 71:510-516.
13. Merk, K., et al. (1990). Epidemiological study of Hodgkin's disease in Cuba and Sweden. Oncology 47:246-250.
14. Hartge, P., Devesa, S.S. and Fraumeni, J.F., Jr. (1994). Hodgkin's and non-Hodgkin's lymphomas. Cancer Surv. 19-20:423-453.
15. Foss Abrahamsen, A., et al. (1997). Hodgkin's disease in a national and hospital population: trends over 20 years. Eur. J. Cancer 33:2380-2383.
16. Liu, S., Semenciw, R., Waters, C., Wen, S.W. and Mao, Y. (2000). Time trends and sex patterns in Hodgkin's disease incidence in Canada, 1970-1995. Can. J. Public Health 91:188-192.
17. Hjalgrim, H., et al. (2001). Incidence of Hodgkin's disease in Nordic countries. Lancet 358:297-298.
18. Seow, A., Lee, J., Sng, I., Fong, C.M. and Lee, H.P. (1996). Non-Hodgkin's lymphoma in an Asian population: 1968-1992: time trends and ethnic differences in Singapore. Cancer 77:1899-1904.
19. Seitz, V., et al. (2000). Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin's disease. Blood 95:3020-3024.
20. Müschen, M., et al. (1991). Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J. Exp. Med. 191:387-394.
21. Marafioti, T., et al. (2000). Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95:1443-1450.
22. Stein, H., et al. (2001). Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 97:496-501.
23. Lam, K.P., Kuhn, R. and Rajewsky, K. (1997). In vivo ablation of surface immunoglobulin on mature B cells by inducable gene targeting results in rapid cell death. Cell 90:1073-1083.
24. Gruss, H.-J., Pinto, A., Duyster, J., Poppema, S. and Herrmann, F. (1997). Hodgkin's disease: a tumor with disturbed immunological pathways. Immunol. Today 4:156-163.
25. Kadin, M.E. and Liebowitz, D.N. (1999). Cytokines and cytokine receptors in Hodgkin's Disease, in Hodgkin's Disease (Mauch, P.M., et al., eds), pp139-157, Lippincott Williams & Wilkins, Philadelphia.
26. Poppema, S. and van den Berg, A. (2000). Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas. Semin. Cancer Biol. 10:345-350.
27. Hsu, P.-L. and Hsu, S.-M. (2000). Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma. Lab. Invest. 80:1111-1119.
28. Kapp, U., et al. (1999). Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J. Exp. Med. 189:1939-1945.
29. Bernhards, J., Fischer, R., Hubner, K., Schwarze, E.-W. and Georgii, A. (1992). Histopathological classification of Hodgkin's lymphoma. Ann. Oncol. 3:31-33.
30. Georgii, A., Fischer, R., Hubner, K., Schwarze, E.W. and Bernhards, J. (1993). Classification of Hodgkin's disease biopsies by a panel of four histopathologists. Report of 1,140 patients from the German National Trial. Leuk. Lymphoma 9:365-370.
31. Rüdiger, T., et al. (1998). Workshop report on Hodgkin's disease and related diseases ("grey zone" lymphoma). Ann. Oncol. 9:31-38.
32. Gatter, K.C. and Warnke, R.A. (2001). Diffuse large B-cell lymphoma, in Tumours of Haematopoietic and Lymphoid Tissue, World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp171-174, IARC, Lyon.
33. Banks, P.M. and Warnke, R.A. (2001). Mediastinal (thymic) large B-cell lymphoma, in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp175-176, IARC, Lyon.
34. Drexler, H.G., Gignac, S.M., von Wasielewski, R., Werner, M. and Dirks, W.G. (2000). Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia 14:1533-1559.
35. Stein, H., et al. (2000). CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96:3681-3695.
36. Delsol, G., Ralfkiaer, E., Stein, H., Wright, D. and Jaffe, E.S. (2001). Anaplastic large cell lymphoma, in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissues. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp230-235, IARC, Lyon.
37. Herling, M., et al. (2001). Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: results with ALK-11 antibody in 327 untreated patients. Leuk. Lymphoma 42:969-979.
38. Jaffe, E.S. (2001). Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopahology. Mod. Pathol. 14:219-228.
39. Ralfkiaer, E., Müller-Hermelink, H.K. and Jaffe, E.S. (2001). Peripheral T-cell lymphoma, unspecified, in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissues. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp227-229, IARC, Lyon.
40. Davies, T., Morton, C., Miller-Cassman, R., Balk, S. and Kadin, M. (1992). Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N. Engl. J. Med. 326:1115-1122.
41. Brousset, P., et al. (1996). Hodgkin's disease following mycosis fungoides: phenotypic and molecular evidence for different tumour cell clones. J. Clin. Pathol. 49:504-507.
42. Marafioti, T., et al. (1997). Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N. Engl. J. Med. 337:453-458.
43. Achten, R., Verhoef, G., Vanuytsel, L. and De Wolf-Peeters, C. (2002). Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 40:31-45.
44. Rüdiger, T., et al. (2002). Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann. Oncol. 13(Suppl. 1):44-51.
45. Jundt, F., et al. (2002). Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood 99(8):3060-3062.
46. Brauninger, A., et al. (1999). Molecular analysis of single B cells from T-cell rich B-cell lymphoma shows the derivation of the tumour cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. Blood 93:2679-2678.
47. Krikorian, J.G., Burke, J.S., Rosenberg, S.A. and Kaplan, H.S. (1979). Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. N. Engl. J. Med. 300:452-458.
48. Kingma, D.W., et al. (1994). Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphoma associated with Hodgkin's disease. Am. J. Surg. Pathol. 18:48-61.
49. Carrato, A., Filippa, D. and Koziner, B. (1987). Hodgkin's disease after treatment of non-Hodgkin's lymphoma. Cancer 60:887-896.
50. Williams, J., Schned, A., Cotelingam, J.D. and Jaffe, E.S. (1991). Chronic lymphocytic leukemia with coexistent Hodgkin's disease: implications for the origin of the Reed-Sternberg cell. Am. J. Surg. Pathol. 15:33-42.
51. Ohno, T., et al. (1998). Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with "Hodgkin's transformation." Blood 91:1757-1761.
52. Momose, H., Jaffe, E.S., Shin, S.S., Chen, Y.Y. and Weiss, L.M. (1992). Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg like cells and possible transformation to Hodgkin's disease: mediation by Epstein-Barr virus. Am. J. Surg. Pathol. 16:859-867.
53. Richter, M.N. (1928). Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am. J. Pathol. 4:285-292.
54. O'Sullivan, M.J., Kaleem, Z., Bolger, M.J., Swanson, P.E. and Zutter, M.M. (2000). Composite prolymphocytoid and hodgkin transformation of chronic lymphocytic leukemia. Arch. Pathol. Lab. Med. 124(6):907-909.
55. Giles, F.J., O'Brien, S.M. and Keating, M.J. (1998). Chronic lymphocytic leukemia in (Richter's) transformation. Semin. Oncol. 25:117.
56. Gonzales, C.L., Medeiros, L.J. and Jaffe, E.S. (1991). Composite lymphoma: a clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma. Am. J. Clin. Pathol. 96:81-89.
57. van den Bergh, A., et al. (2002). Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma. Blood 100(4):1425-1429.
58. Niedobitek, G., et al. (2000). Hodgkin's disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection. J. Pathol. 191(4):394-399.
59. Wlodarska, I., et al. (1993). T-Cell lymphoma developing in Hodgkin's disease: evidence for two clones. J. Pathol. 170:239-248.
60. Kremer, M., et al. (2001). Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin. Mod. Pathol. 14:91-97.
61. Hawkins, K.A., et al. (1983). Simultaneous occurrence of mycosis fungoides and Hodgkin's disease: clinical and histologic correlations in three cases with ultrastructural studies in two. Am. J. Hematol. 14:355-362.
62. Bee, C.S., Blaise, Y.P. and Dunphy, C.H. Composite lymphoma of Hodgkin lymphoma and mycosis fungoides: previously undescribed in the same extracutaneous site. Leuk. Lymphoma 42:543-549.
63. Greene, M.H., et al. (1982). Lymphomas and leukemias in the relatives of patients with mycosis fungoides. Cancer 49:737-741.
64. Brauninger, A., et al. (1999). Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N. Engl. J. Med. 340:1239-1247.
65. Küppers, R., et al. (2001). Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL. Mol. Med. 7:285-292.
66. Barrios, L., et al. (1988). Chromosomal abnormalities in peripheral blood lymphocytes from untreated Hodgkin's patients. A possible evidence for genetic instability. Hum. Genet. 78:320-324.
67. M'kacher, R., et al. (2001). Treatment induced chromocomal aberrations in circulating lymphocytes in patients with Hodgkin's disease. Leuk. Lymphoma 42:35 (abstract).
68. Müller-Hermelink, H.K., Zettl, A., Pfeifer, W. and Ott, G. (2001). Pathology of lymphoma progression. Histopathology 38:285-306.
69. Amini, R.-M., et al. (2002). A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma. Leuk. Lymphoma 43:2179-2189.
70. Cazals-Hatem, D., et al. (2001). Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study. Am. J. Surg. Pathol. 25:297-306.
71. Enblad, G., Gustafsson, A., Sundström, C. and Glimelius, B. (2002). Elderly patients with Hodgkin lymphoma treated with a new treatment strategy. Acta Oncolo., in press.